Advertisement

Assessment of Psychological Concomitants of Oral Contraceptives

  • Rudolf H. Moos

Abstract

This paper will review research on the menstrual cycle and on oral contraceptives currently in progress in the Department of Psychiatry at Stanford University. The psychological aspect of the work is oriented around two major purposes. The first is an attempt to develop a standard technique for the assessment of symptoms and change of symptoms throughout the menstrual cycle. The second involves the comparison of women on oral contraceptives with women not on oral contraceptives in terms of the symptom changes throughout their menstrual cycles.

Keywords

Menstrual Cycle Oral Contraceptive Premenstrual Symptom Menstrual Phase Autonomic Reaction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Food and Drug Administration Report on Oral Contraceptives by the Advisory Committee on Obstetrics and Gynecology, F.D.A., Aug. 1, 1966.Google Scholar
  2. 2.
    Pincus, G.: Control of conception by hormonal steroids. Science 153:493–500 (1966).PubMedCrossRefGoogle Scholar
  3. 3.
    Ryder, N.B. and Westoff, C.F.: Use of oral contraception in the United States, 1965. Science 155:1199–1205 (1966).CrossRefGoogle Scholar
  4. 4.
    Ratner, H.: Oral contraception drop-out rate. Science 155:951 (1967).PubMedCrossRefGoogle Scholar
  5. 5.
    Moos, R.H, and Baker, K.: Literature review and summary t of the premenstrual tension syndrome. Unpublished research report, Stanford University, 1965.Google Scholar
  6. 6.
    Altman, M, Knowles, E. and Bull, H.: A psychometric study of the sex cycle in women. Psychosom. Med. 3:199(1941).Google Scholar
  7. 7.
    Greene, R. and Dalton, K.: The premenstrual syndrome. Brit. Med. J. 1:1007 (1953).PubMedCrossRefGoogle Scholar
  8. 8.
    Paulson, M,: Psychological concomitants of premenstrual tension. Doctoral dissertation, University of Kansas, 1956.Google Scholar
  9. 9.
    Coppen, A. and Kessel, N.: Menstruation and personality. Brit. J. Psychiat. 109:711 (1963).PubMedCrossRefGoogle Scholar
  10. 10.
    Sutherland, H. and Steward, I.: A critical analysis of the premenstrual syndrome. Lancet i:1180 (1965).CrossRefGoogle Scholar
  11. 11.
    Blatt, M., Wiesbader, H. and Kupperman, H.: Vitamin E and climacteric syndrome. A.M.A. Arch. Int. Med. 91:792 (1953).Google Scholar
  12. 12.
    Neugarten, B. and Kraines, R.: Menopausal symptoms in women of various ages. Psychosom. Med. 27:266 (1965).PubMedGoogle Scholar
  13. 13.
    Moos, R.H.: The development of a menstrual distress questionnaire. Psychosom. Med., In Press.Google Scholar
  14. 14.
    Moos, R.H.: A typology of menstrual cycle symptoms. Amer. J. Obstet. Gynecol. In Press.Google Scholar
  15. 15.
    Moos, R.H., Kopell, B.S., Melges, F.T., Yalom, I.D., Lunde, D.T., Clayton, R.B. and Hamburg, D.A.: Variations in symptoms and mood during the menstrual cycle. J. Psychosom. Res. In Press.Google Scholar
  16. 16.
    Moos, R.H.: Psychological aspects of oral contraceptives. Archives of General Psychiatry 19:87–94 (1968).PubMedCrossRefGoogle Scholar
  17. 17.
    Drill, V.A.: Oral Contraceptives. New York: McGraw-Hill Book Co., Inc., 1966.Google Scholar
  18. 18.
    Goldstein, A.: Biostatistics: An Introductory Text, New York, Macmillan Co., Publishers, 1964.Google Scholar
  19. 19.
    Click, I.D.: Mood and behavioral changes associated with the use of the oral contraceptive agents—A review of the literature. Psychopharmacologia 10:363–374 (1967).CrossRefGoogle Scholar
  20. 20.
    Newlis, V.: Research with the mood adjective check list. In Affect Cognition and Personality, Tomkins, S. and Izard, C. (eds.), New York, Springer, pp. 353–389 (1965).Google Scholar
  21. 21.
    Harmon, H.H.: Modem Factor Analysis. University of Chicago Press, Chicago, 1960.Google Scholar
  22. 22.
    Binks, E., Caniboum, P. and Papworth, R.A.: Preliminary report of a clinical trial of oral norethynodrel for fertility control. Med. J. Aust. 49(1):716–717 (1962).PubMedGoogle Scholar
  23. 23.
    Pullen, D.: "Conovid-E" as an oral contraceptive. Brit. Med. J. 1016–1019 (1962).Google Scholar
  24. 24.
    Goldzieher, J.W., Moses, I.E. and Ellis, L.T.: Study of norethindrone in contraception. JAMA 180:359–361 (1962).CrossRefGoogle Scholar
  25. 25.
    Mears, E. and Grant, E.C.G.: "Anovlar" as an oral contraceptive, Brit. Med. J. 2:75–79 (1962).CrossRefGoogle Scholar
  26. 26.
    Gould, J.: Control of ovulation with Provest. Int. J. Fertil. 8:737–741 (1963).PubMedGoogle Scholar
  27. 27.
    Andrews, W.C. and Andrews, M.C.: The use of progestins for oral contraception. Southern Med. J. 55:454–456 (1962).PubMedCrossRefGoogle Scholar
  28. 28.
    Rice-Wray, E., Schultz-Contreras, M., Guerrero, I. and Aranda-Rosell, A.: Long-term administration of norethindrone in fertility control. JAMA 180:355–358 (1962).CrossRefGoogle Scholar
  29. 29.
    Andrews, W.C. and Andrews, M.C.: Reduction of side-effects from ovulation suppression by the use of newer-progestin conbina- tions. Fertil. Steril. 15:75–83 (1964).PubMedGoogle Scholar
  30. 30.
    Jungck, E.C.: Sequential estrogen-progestogen therapy in gynecology. Amer. J. Obstet. Gynec. 94:165–169 (1966).PubMedGoogle Scholar
  31. 31.
    Dickinson, J.H. and Smith, G.G.: Anew and practical oral contraceptive agent: norethindrone with mestranol. Canad. Med. Assoc. J. 89:242–245 (1963).PubMedGoogle Scholar
  32. 32.
    Wearing, M.P.: The use of norethindrone (two mg) with mestranol (one mg) in fertility control. Canad. Med. Assoc. J. 89:239–241 (1963).PubMedGoogle Scholar
  33. 33.
    Kaye, B.M.: Oral contraceptives and depression. JAMA 186:522 (1963).CrossRefGoogle Scholar
  34. 34.
    Kane, F., Daly, R., Ewing, J. and Keeler, M.: Mood and behavioral changes with progestational agents. Brit. J. Psychiat. 113:265–268 (1967).PubMedCrossRefGoogle Scholar
  35. 35.
    Daly, R.J., Kane, F.J. and Ewing, J.A.: Psychosis associated with the use of a sequential oral contraceptive. Lancet ii:444–445 (1967).CrossRefGoogle Scholar
  36. 36.
    Nillson, A. and Almgren, P.E.: Psychiatric symptoms during the postpartum period as related to use of oral contraceptives. Brit. Med. J. 2:453–455 (1968).CrossRefGoogle Scholar
  37. 37.
    Nillson, A., Jacobson, L. and Ingemanson, C.A.: Side- effects of an oral contraceptive with particular attention to mental symptoms and sexual adaptation. Acta. Obst, et Gynec. Scand. 46:537–556 (1967).CrossRefGoogle Scholar
  38. 38.
    Nillson, L. and Solvell, L.: Clinical studies on oral contraceptives - α randomized doubleblind crossover study of four different preparations (Anovlar mite, Lyndiol mite, Ovulen and Volidan. Acta Obst, et Gynec. Scand. 46:537–556 (1967).CrossRefGoogle Scholar
  39. 39.
    Pincus, G.: Frontiers in methods of fertility control. In Human Fertility and Population Problems, Greep, R.O. (ed.), Schenkman Publishing Co., Inc., Cambridge, Mass., pp. 177–203 (1963).Google Scholar
  40. 40.
    Pincus, G.: The Control of Fertility. Academic Press, Inc., New York, 1965.Google Scholar
  41. 41.
    Pincus, G.: Long term administration of Enovid to human subjects. In Proceedings of Symposium on 19-Norprogestational Steroids, G.D. Searle and Co., Chicago, p. 105 (1957).Google Scholar
  42. 42.
    Carter, A.C., Feldman, E.B. and Wallace, E.Z.: The effects of steroids on the levels of the plasma 17-hydroxycortico- steroids and the serum protein-bound iodine. In Biological Activities of Steroids in Relation to Cancer, Pincus, G. and Vollmer, E.P. (eds.), Academic Press, Inc., New York, p. 77 (1960).Google Scholar
  43. 43.
    Matsuükto, S., Sato, I., Ito, T. and Matsuoka, A.: Elec- troencephalographic changes during long term treatment with oral contraceptives. Int, J. Fertil. 11:195–204 (1966).Google Scholar
  44. 44.
    Sawyer, C.H.: Neuroendocrine Blocking Agents: Discussion In Advances in Neuroendocrinology, University of Illinois Press, Urbana, 111., pp. 451–459 (1963).Google Scholar
  45. 45.
    King, A.G.; Selection of patients for the intrauterine contraceptive device. Obstet. Gynec. 29: 139–141 (1967).PubMedGoogle Scholar
  46. 46.
    Silbar, E.L. and Solomon, E.M.; Intrauterine contraception and the private patient. Clin. Med. 74:25–27 (1967).Google Scholar

Copyright information

© Plenum Press, New York 1969

Authors and Affiliations

  • Rudolf H. Moos
    • 1
  1. 1.Department of PsychiatryStanford University School of MedicineCaliforniaUSA

Personalised recommendations